The Effects of Fx-1006A on Transthyretin Stabilization and Clinical Outcome Measures in Patients With Non-V30M Transthyretin Amyloidosis - Related Studies

Home

Study Topics

Glossary


	Full Text View


	Tabular View


	Contacts and Locations


	No Study Results Posted


	Related Studies

The Effects of Fx-1006A on Transthyretin Stabilization and Clinical Outcome Measures in Patients With Non-V30M Transthyretin Amyloidosis

This study is currently recruiting participants.

Study NCT00630864. Last updated on November 12, 2008. Information provided by FoldRx Pharmaceuticals

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Additional conditions recognized in this trial
		Amyloidosis
		Polyneuropathies

2	More general conditions related to this trial
		Metabolic Diseases
		Nervous System Diseases
		Neuromuscular Diseases
		Peripheral Nervous System Diseases

3	Interventions listed in this trial
		Fx-1006A

4	Sponsors listed in this trial
		FoldRx Pharmaceuticals